MITRAGYNINE PICRATE
- CAS NO.:4098-40-2
- Empirical Formula: C23H30N2O4
- Molecular Weight: 398.5
- MDL number: MFCD00189432
- EINECS: 200-659-6
- SAFETY DATA SHEET (SDS)
- Update Date: 2023-07-21 14:17:16
What is MITRAGYNINE PICRATE?
Description
This alkaloid has been isolated from Mitragyna speciosa Korth, and is amorphous
although it yields a series of crystalline salts and derivatives. The hydrochloride
crystallizes as colourless leaflets from EtOH-Et20 with m.p. 243°C; the picrate
forms thin, orange-red needles, m.p. 223-4°C and the methiodide is a pale
yellow powder which, although amorphous, has a sharp melting point of
21 1. 5°C. The alkaloid also forms compounds with acetic acid, m.p. 142°C,
decomposing at 175-6°, and with trichloroacetic acid, m.p. 157°C.
Mitragynine exerts a general depressant effect on plain muscle and facilitates
the passage of autonomic impulses. It is, however, ineffective against pathogenic
organisms.
Description
Mitragynine is the predominant alkaloid produced by the southeastern Asian plant?Mitragyna speciosa?Korth., a member of the coffee family (Rubiaceae). It was isolated in 1921 by Ellen Field, a medicinal chemist at the University of Edinburgh.
M. speciosa, known locally as kratom, has been used in traditional medicine for ≈200 years. It has opiate-like properties and has been used to treat chronic pain and opioid withdrawal symptoms. More recently, it has come into recreational use. Clinical studies on kratom and mitragynine are just beginning.
In September 2016, the US Drug Enforcement Administration (DEA)?designated kratom, mitragynine, and one of its derivatives as Schedule I substances. Schedule 1 is the most restrictive category under the US Controlled Substances Act. DEA cited the lack of information on mitragynine and reports of adverse reactions—even death—from taking kratom.
Researchers studying the medical use of mitragynine and its pseudoindoxyl derivative decried the Schedule I classification. One of them, Andrew C. Kruegel at Columbia University, said, “Placing these compounds into Schedule I will erect an enormous barrier to scientific research in this field and will dramatically curtail our work with this exciting plant.”
Chemical properties
White to Off-White Solid
The Uses of MITRAGYNINE PICRATE
A neurochemical, having both stimulant and opiate-like effects depending on the dosage. Currently, Mitragynin is being investigated for its ability to treat hard drug addiction.
The Uses of MITRAGYNINE PICRATE
Mitragynine is a neurochemical, having both stimulant and opiate-like effects depending on the dosage. Currently, Mitragynine is being investigated for its ability to treat hard drug addiction.
Definition
ChEBI: Mitragynine is a monoterpenoid indole alkaloid.
References
Field., J. Chern. Soc., 119,887 (1921)
Raymond-Hamet, Millat., Bull. sci. pharrnacol., 40, 593 (1933)
lng, Raison., J. Chern. Soc., 986 (1939)
Loudon., Chern. Soc. Spec. Publ., 3, 12 (1955)
Hendrickson., Chern. & Ind., 713 (1961)
Joshi, Raymond-Hamet, Taylor., ibid, 573 (1963)
Pharmacology:
Grewal., J. Pharrn. expo Ther., 46,251 (1932)
Properties of MITRAGYNINE PICRATE
Melting point: | 92-95°C |
Boiling point: | bp5 230-240° |
alpha | D +39° (chloroform) |
Density | 1.22±0.1 g/cm3 (20 ºC 760 Torr) |
Flash point: | 9℃ |
storage temp. | -20°C Freezer |
solubility | Chloroform (Slightly), Methanol (Slightly) |
form | Solid |
pka | 18.35±0.60(Predicted) |
color | Light Orange to Dark Beige to Very Dark Yellow |
Safety information for MITRAGYNINE PICRATE
Signal word | Danger |
Pictogram(s) |
Flame Flammables GHS02 Skull and Crossbones Acute Toxicity GHS06 Health Hazard GHS08 |
GHS Hazard Statements |
H225:Flammable liquids H370:Specific target organ toxicity, single exposure |
Precautionary Statement Codes |
P210:Keep away from heat/sparks/open flames/hot surfaces. — No smoking. P260:Do not breathe dust/fume/gas/mist/vapours/spray. P280:Wear protective gloves/protective clothing/eye protection/face protection. P311:Call a POISON CENTER or doctor/physician. P301+P310:IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
Computed Descriptors for MITRAGYNINE PICRATE
New Products
4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HCL 4-(Dimethylamino)tetrahydro-2H-pyran-4-carbonitrile 4-Aminotetrahydropyran-4-carbonitrile Hydrochloride (R)-3-Aminobutanenitrile Hydrochloride 3-((Dimethylamino)methyl)-5-methylhexan-2-one oxalate 1,4-Dioxa-8-azaspiro[4.5]decane 5-Bromo-2-nitropyridine Nimesulide BP Aceclofenac IP/BP/EP Diclofenac Sodium IP/BP/EP/USP Mefenamic Acid IP/BP/EP/USP Ornidazole IP Diclofenac Potassium THOMAIND PAPER PH 2.0 TO 4.5 1 BOX BUFFER CAPSULE PH 9.2 - 10 CAP SODIUM CHLORIDE 0.1N CVS ALLOXAN MONOHYDRATE 98% PLATINUM 0.5% ON 3 MM ALUMINA PELLETS (TYPE 73) LITHIUM AAS SOLUTION 2-Bromo-1-(bromomethyl)-3-chloro-5-nitrobenzene 2-Bromo-3-nitroaniline N-(3-Hydroxypropyl)-N-methylacetamide 3-Bromo-6-chloropyridazine 4-ethyl-3-nitrobenzoic acidRelated products of tetrahydrofuran
You may like
-
Mitragynine 98% (HPLC) CAS 4098-40-2View Details
4098-40-2 -
Mitragynine solution CAS 4098-40-2View Details
4098-40-2 -
Mitragynine solution CAS 4098-40-2View Details
4098-40-2 -
1823368-42-8 98%View Details
1823368-42-8 -
2-(3-(tert-butyl)phenoxy)-2-methylpropanoic acid 1307449-08-6 98%View Details
1307449-08-6 -
Ethyl 3-(furan-2-yl)-3-hydroxypropanoate 25408-95-1 98%View Details
25408-95-1 -
2-Chloro-5-fluoro-1-methoxy-3-methylbenzene 98%View Details
1805639-70-6 -
Lithium ClavulanateView Details
61177-44-4